Shareholding disclosure

Rudolf Maag

Declared position

1.74%

Threshold

Crossed upwards

Timeline

Published

28.02.2014

Transaction

18.02.2014

Voting rights breakdown

Voting rights acquired1.74%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE2Q00075

Beneficial owner

Rudolf Maag

Declared address

Rudolf MAAG, 4102 Binningen

Die Firma ist zu 100% beherrscht von Rudolf Maag

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Rudolf Maag

Addex Therapeutics Ltd28.02.2014TAE2Q00075

Disclosure summary

Rudolf Maag disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 28.02.2014, at 1.74% of voting rights. Notice category: Single shareholder.

Disclosed position

1.74%

Voting rights acquired

Voting rights acquired1.74%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Rudolf Maag disclosed a holding in Addex Therapeutics Ltd, published on 28.02.2014.

Publication date28.02.2014

Transaction date18.02.2014

Issuing companyAddex Therapeutics Ltd

Beneficial ownerRudolf Maag

Declared addressRudolf MAAG, 4102 Binningen

CategorySingle shareholder

Voting rights acquired1.74%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAE2Q00075

Conditions

Die Firma ist zu 100% beherrscht von Rudolf Maag

Source: SIX Exchange Regulation · Publication date: 28.02.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open